Skip to content
Clinical Research Made Simple

Clinical Research Made Simple

Trusted Resource for Clinical Trials, Protocols & Progress

Tag: decentralized trials and recruitment

Patient Recruitment and Retention in Clinical Trials: Strategies for Successful Enrollment and Long-Term Engagement

Posted on May 15, 2025 digi By digi

Patient Recruitment and Retention in Clinical Trials: Strategies for Successful Enrollment and Long-Term Engagement Essential Strategies for Enhancing Patient Recruitment and Retention in Clinical Trials Patient recruitment and retention are among the most critical—and most challenging—aspects of clinical trial success. Timely enrollment and sustained participant engagement directly impact study timelines, data quality, regulatory approval, and…

Read More “Patient Recruitment and Retention in Clinical Trials: Strategies for Successful Enrollment and Long-Term Engagement” »

Patient Recruitment and Retention

Recruitment Strategies in Clinical Trials: Proven Tactics to Enhance Patient Enrollment

Posted on May 9, 2025 digi By digi

Recruitment Strategies in Clinical Trials: Proven Tactics to Enhance Patient Enrollment Innovative and Practical Recruitment Strategies to Boost Clinical Trial Enrollment Patient recruitment remains one of the most significant challenges in clinical research, with nearly 80% of trials experiencing enrollment delays or under-enrollment. Implementing targeted, patient-centric recruitment strategies is essential to reach enrollment goals efficiently…

Read More “Recruitment Strategies in Clinical Trials: Proven Tactics to Enhance Patient Enrollment” »

Patient Recruitment and Retention, Recruitment Strategies

Quick Guide

  • Clinical Trial Phases
    • Preclinical Studies
    • Phase 0 (Microdosing Studies)
    • Phase 1 (Safety and Dosage)
    • Phase 2 (Efficacy and Side Effects)
    • Phase 3 (Confirmation and Monitoring)
    • Phase 4 (Post-Marketing Surveillance)
  • Regulatory Guidelines
  • Clinical Trial Design and Protocol Development
  • Good Clinical Practice (GCP) and Compliance
  • U.S. FDA Regulations

Menu

Recent Posts

  • Labeling Negotiations and Risk Communication After Phase 3 Trials: Process, Stakeholders, and Best Practices
  • Early Stopping Rules in Phase 1 Trials: Safety, PK, and Futility Criteria
  • Phase 4 Trials in Vaccine Safety Monitoring: Ensuring Public Trust Through Real-World Surveillance
  • Real-World Data (RWD) Integration into Phase 2 Design and Interpretation
  • Global Regulatory Variations in Accepting Phase 3 Data: Guidelines, Differences, and Submission Strategies

Copyright © 2025 Clinical Research Made Simple.

Powered by PressBook WordPress theme